Wang SJ - Search Results

1

Use of two-stage test statistic in the two-period crossover trials.

Wang SJ, Hung HM. Wang SJ, et al. Biometrics. 1997 Sep;53(3):1081-91. Biometrics. 1997. PMID: 9333341

2

Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.

Wang SJ, Hung HM, Tsong Y, Cui L. Wang SJ, et al. Stat Med. 2001 Jul 15;20(13):1903-12. doi: 10.1002/sim.820. Stat Med. 2001. PMID: 11427948

3

Modification of sample size in group sequential clinical trials.

Cui L, Hung HM, Wang SJ. Cui L, et al. Among authors: wang sj. Biometrics. 1999 Sep;55(3):853-7. doi: 10.1111/j.0006-341x.1999.00853.x. Biometrics. 1999. PMID: 11315017

4

Large sample tests for binary outcomes in fixed-dose combination drug studies.

Wang SJ, Hung HM. Wang SJ, et al. Biometrics. 1997 Jun;53(2):498-503. Biometrics. 1997. PMID: 9192448

5

Challenges in regulating breakthrough medical devices.

Muni NI, Gross TP, Boam AB, Wang S, Zuckerman BD. Muni NI, et al. Food Drug Law J. 2005;60(2):137-42. Food Drug Law J. 2005. PMID: 16097092 No abstract available.

6

Clinical characteristics and long-term outcome of cerebral cavernous malformations-related epilepsy.

Shih YC, Chou CC, Peng SJ, Yu HY, Hsu SPC, Lin CF, Lee CC, Yang HC, Chen YC, Kwan SY, Chen C, Wang SJ, Lin CJ, Lirng JF, Shih YH, Yen DJ, Liu YT. Shih YC, et al. Among authors: wang sj. Epilepsia. 2022 May 20. doi: 10.1111/epi.17309. Online ahead of print. Epilepsia. 2022. PMID: 35593439

7

Two new constituents from the aerial parts of Salvia miltiorrhiza Bge.

Yang F, Li J, Du XL, Wang SJ, Xu XH, Zhang YQ, Yang R. Yang F, et al. Among authors: wang sj. Nat Prod Res. 2022 May 19:1-8. doi: 10.1080/14786419.2022.2078324. Online ahead of print. Nat Prod Res. 2022. PMID: 35587643

8

Molecular Mechanism of Polysaccharides Extracted from Chinese Medicine Targeting Gut Microbiota for Promoting Health.

Zhao WX, Wang T, Zhang YN, Chen Q, Wang Y, Xing YQ, Zheng J, Duan CC, Chen LJ, Zhao HJ, Wang SJ. Zhao WX, et al. Among authors: wang sj. Chin J Integr Med. 2022 May 18. doi: 10.1007/s11655-022-3522-y. Online ahead of print. Chin J Integr Med. 2022. PMID: 35583582 Review.

9

Relieving patent-eligibility barriers in biotech with a preparation or treatment method.

Wang JY, Tsai YF, Wang TH, Wang SJ. Wang JY, et al. Among authors: wang sj. Nat Biotechnol. 2022 May;40(5):651-653. doi: 10.1038/s41587-022-01301-6. Nat Biotechnol. 2022. PMID: 35577940 No abstract available.

10

CGRP Targeting Therapy for Chronic Migraine-Evidence from Clinical Trials and Real-world Studies.

Wang YF, Wang SJ. Wang YF, et al. Among authors: wang sj. Curr Pain Headache Rep. 2022 May 14. doi: 10.1007/s11916-022-01056-4. Online ahead of print. Curr Pain Headache Rep. 2022. PMID: 35567661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results